These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12704332)

  • 1. Can epsilon-aminocaproic acid balance the off-pump bleeding advantage?
    Stassano P; Musumeci A; Santise G; Gagliardi C; Montalto A; Spampinato N
    Cardiovasc Surg; 2003 Jun; 11(3):219-23. PubMed ID: 12704332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
    Menichetti A; Tritapepe L; Ruvolo G; Speziale G; Cogliati A; Di Giovanni C; Pacilli M; Criniti A
    J Cardiovasc Surg (Torino); 1996 Aug; 37(4):401-7. PubMed ID: 8698787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial.
    Bennett-Guerrero E; Sorohan JG; Gurevich ML; Kazanjian PE; Levy RR; Barberá AV; White WD; Slaughter TF; Sladen RN; Smith PK; Newman MF
    Anesthesiology; 1997 Dec; 87(6):1373-80. PubMed ID: 9416723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin.
    Greilich PE; Brouse CF; Whitten CW; Chi L; Dimaio JM; Jessen ME
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1498-503. PubMed ID: 14666025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit.
    Ray MJ; Hales MM; Brown L; O'Brien MF; Stafford EG
    Ann Thorac Surg; 2001 Aug; 72(2):521-6. PubMed ID: 11515892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting.
    Troianos CA; Sypula RW; Lucas DM; D'Amico F; Mathie TB; Desai M; Pasqual RT; Pellegrini RV; Newfeld ML
    Anesthesiology; 1999 Aug; 91(2):430-5. PubMed ID: 10443606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Control of postoperative hemorrhage in isolated coronary bypass surgery: comparison of tranexamic acid effects in off-pump surgery with aprotinin effects in conventional surgery].
    Bordalo AD; Nobre AL; Silva F; Serpa C; Cravino J
    Rev Port Cir Cardiotorac Vasc; 2011; 18(3):143-8. PubMed ID: 23596616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative Bleeding.
    Choudhuri P; Biswas BK
    Ethiop J Health Sci; 2015 Jul; 25(3):273-8. PubMed ID: 26633931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study.
    Daily PO; Lamphere JA; Dembitsky WP; Adamson RM; Dans NF
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):99-106; discussion 106-8. PubMed ID: 8028387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis.
    Munoz JJ; Birkmeyer NJ; Birkmeyer JD; O'Connor GT; Dacey LJ
    Circulation; 1999 Jan 5-12; 99(1):81-9. PubMed ID: 9884383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of effectiveness of tranexamic acid and epsilon-amino-caproic-acid in decreasing postoperative bleeding in off-pump CABG surgeries: A prospective, randomized, double-blind study.
    Verma S; Srinivas U; Sathpathy AK; Mittal P
    Ann Card Anaesth; 2020; 23(1):65-69. PubMed ID: 31929250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of epsilon-aminocaproic acid to reduce bleeding.
    Lemmer JH
    J Thorac Cardiovasc Surg; 1997 Jun; 113(6):1125-7. PubMed ID: 9202701
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of low-dose aprotinin, epsilon-aminocaproic acid or tranexamic acid for prevention of mediastinal bleeding in patients receiving aspirin before coronary artery bypass operations.
    Landymore RW; Murphy JT; Lummis H; Carter C
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):798-800. PubMed ID: 9151061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery.
    Durand M; Chavanon O; Tessier Y; Meyer C; Casez M; Bach V; Maitrasse B; Girardet P
    J Card Surg; 2006; 21(1):17-21. PubMed ID: 16426342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome.
    Martin K; Gertler R; MacGuill M; Mayr NP; Hapfelmeier A; Hörer J; Vogt M; Tassani P; Wiesner G
    Br J Anaesth; 2013 Apr; 110(4):615-21. PubMed ID: 23213034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid.
    Vander Salm TJ; Kaur S; Lancey RA; Okike ON; Pezzella AT; Stahl RF; Leone L; Li JM; Valeri CR; Michelson AD
    J Thorac Cardiovasc Surg; 1996 Oct; 112(4):1098-107. PubMed ID: 8873738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.